verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: wilshire pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler wilshire pharmaceuticals, inc.
Dosage Form CAPSULE, DELAYED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 180 mg/1

Manufacturer
Wilshire Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 52536-882
Product ID 52536-882_27eb9340-eaec-754a-e063-6394a90a4f6e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA019614
Listing Expiration 2026-12-31
Marketing Start 1990-05-29

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 52536882
Hyphenated Format 52536-882

Supplemental Identifiers

UPC
0352536886017 0352536882019
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number NDA019614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (52536-882-01)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (180 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "27eb9340-eaec-754a-e063-6394a90a4f6e", "openfda": {"upc": ["0352536886017", "0352536882019"], "unii": ["V3888OEY5R"], "spl_set_id": ["f9399858-fd7a-4b73-8759-3e5bf3af2666"], "manufacturer_name": ["Wilshire Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (52536-882-01)", "package_ndc": "52536-882-01", "marketing_start_date": "20241126"}], "brand_name": "Verapamil Hydrochloride", "product_id": "52536-882_27eb9340-eaec-754a-e063-6394a90a4f6e", "dosage_form": "CAPSULE, DELAYED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "52536-882", "generic_name": "verapamil hydrochloride", "labeler_name": "Wilshire Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "NDA019614", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19900529", "listing_expiration_date": "20261231"}